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Edited by Beat ImhofAbstract Peroxynitrite, via post-translational modiﬁcations to
target proteins, contributes to cardiovascular injury and cancer.
Since tissue inhibitor of metalloproteinase-4 (TIMP-4), the
activity of which is impaired in both pathological conditions,
has several amino acid residues susceptible to peroxynitrite, we
investigated its role as a potential target of peroxynitrite. Perox-
ynitrite-induced nitration and oligomerization of TIMP-4 atten-
uated its inhibitory activity against MMP-2 activity and
endothelial or tumor cell invasiveness. Moreover, cell treatment
with peroxynitrite promoted the nitration of endogenous
TIMP-4. HPLC/ESI-MS/MS analysis of peroxynitrite-treated
TIMP-4 showed modiﬁcations at Y114, Y195, Y188 and
Y190. In conclusion, TIMP-4 nitration might be a potential
mechanism contributing to cardiovascular disease and cancer.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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stress1. Introduction
Matrix metalloproteinases (MMPs), involved in the remod-
elling of the extracellular matrix and in the processing of bio-
logically active molecules, are activated either by proteolytic
removal of an autoinhibitory amino terminal domain, or by
conformantional changes induced by denaturing or oxidizing
agents such as peroxynitrite (ONOO) [1]. Among this enzyme
family, MMP-2 is widely recognized as having an important
role in pathophysiological conditions such as angiogenesis,
atherosclerosis and heart failure [2–4]. MMP activity is regu-
lated by four homologous molecules, termed tissue inhibitors
of metalloproteinases (TIMPs) [4]. TIMP-4 mRNA is upregu-
lated in the heart in response to vascular injury, in certain can-
cers, and in peritumor stroma [5,6], suggesting its protective
eﬀect in cardiomyopathy, and tumor progression. TIMP-4 is
synthesized as a chain of 224 amino acids possessing a consen-
sus signal peptide and is released as a mature protein of 195
amino acids, having a molecular mass of 22 kDa. The protein*Corresponding author. Fax: +39 0577 234439.
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doi:10.1016/j.febslet.2008.02.080structure of TIMP-4 shares several essential features that are
characteristic of the TIMP family, including 12 conserved cys-
teine residues forming intrachain disulﬁde bonds that fold the
protein into a two domain structure [7]. TIMPs work by asso-
ciation with MMP zymogens, and TIMP-4, like TIMP-2, is a
potent inhibitor of MMP-2, MMP-9 and membrane-type1-
MMP [8].
Nitrated proteins isolated from human tissues obtained from
various diseases can derive from activity of ONOO, produced
by the reaction of nitric oxide (NO) with superoxide (O2 ), as
well as from activity of peroxidases in the presence of nitrite
and hydrogen peroxide [9,10]. ONOO reacts with numerous
molecules. In particular, ONOO-induced protein oxidation
often leads to loss of protein activity [11], seldom to activation
[1,2].
We investigated whether hTIMP-4 was susceptible to inacti-
vation by nitrative stress in the form of ONOO and whether
ONOO may aﬀect the balance between TIMP-4 and MMP-2
activities in endothelial and tumor cell lines. Our results indi-
cate that TIMP-4 is a target of ONOO. Nitration of TIMP-
4 by ONOO signiﬁcantly attenuates its inhibitory constraint
on MMP-2, resulting in enhanced cell invasiveness.2. Materials and methods
2.1. Reagents
Bovine calf serum (BCS) and fetal calf serum (FCS) were from Hy-
clone. All other reagents were from Sigma–Aldrich, unless otherwise
speciﬁed. Enterokinase was from Roche and ﬁbroblast growth fac-
tor-2 (FGF-2) was from Calbiochem.
2.2. Cloning expression, puriﬁcation and refolding of human TIMP-4
The cDNA of human TIMP-4 was kindly provided by Dr. Nagase
(Imperial College, London, UK). DNA encoding for human active
TIMP-4 (aa 30–224) [12] was ampliﬁed and subcloned into a pTrcHis
vector downstream of the enterokinase recognition sequence (Asp Asp
Asp Asp Lys) in order to express a 6 ·HisTag-TIMP-4. Cloned
TIMP-4 was puriﬁed by two-step chromatography, and refolded by
dialysis against urea (details in SM).
2.3. ONOO preparation
ONOO was prepared as reported [13]. Brieﬂy, ONOO was
obtained by reaction of NaNO2 and H2O2 in acid medium (HCl)
and stored in NaOH solution. Excess H2O2 was removed by treatment
with MnO2. The concentration of ONOO
 was determined spectro-
photometrically by its absorbance at 302 nm in 1 N NaOH. To obtain
the decomposed ONOO (DCP) (vehicle control), 1 ml of ONOO
was incubated at room temperature for 24 h.blished by Elsevier B.V. All rights reserved.
Fig. 1. (A) Western blot analysis for nitrotyrosine residues. Repre-
sentative gel out of three. (B) Western blot analysis for hTIMP-4.
Representative gel out of three. Arrows indicate the presence of
aggregates of TIMP-4. C = control (no ONOO in the reaction
mixture) and DCP (5 mM) = decomposed ONOO.
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The procedure was previously described [14]. After SDS/15% PAGE,
proteins were transferred onto a polyvinylidene diﬂuoride membrane
(Amersham). A rabbit polyclonal primary antibody directed against
nitrotyrosine (Calbiochem), diluted 1:1000 in PBS (4 C overnight),
was used. Membranes were incubated for 1 h at 23 C with horseradish
peroxidase-conjugated anti-rabbit secondary antibody (Promega)
diluted 1:5000 in PBS, followed by detection using a chemilumines-
cence kit (Bio-Rad). Blots were stripped, equilibrated in PBS and incu-
bated overnight at 4 C with a sheep primary anti-TIMP-4 antibody
(Calbiochem) diluted 1:1000 in PBS, followed by 1 h with secondary
anti-sheep IgG (Kirkegaard & Perry Laboratories Inc.) diluted
1:2000 in PBS.
2.5. Cell cultures
CVEC (coronary post-capillary venular endothelial cells) from
bovine heart were cultured in DMEM as described [14]. The human
tumor ﬁbrosarcoma cell line (HT1080), obtained from ATCC, was cul-
tured in DMEM with 4.5 g glucose/L in the presence of 10% FCS.
2.6. Cell invasion
Cell invasion was assessed in the 48-well microchemotaxis chamber
on a polycarbonate ﬁlter 8 lm pore size coated with 1 mg/ml gelatine
[14]. 50 ll of cell suspension (1.2 · 104 for CVEC or 5 · 104 for
HT1080) were added to the upper wells. Where indicated, cells were
treated (30 min) with hTIMP-4 pretreated with/without ONOO
(500 lM). FGF-2 (20 ng/ml) served as chemoattractant in the lower
wells. After incubation of CVEC (4 h) or HT1080 (18 h) at 37  C,
non migrated cells were removed and the ﬁlter was stained with Diﬀ
Quik (Biomap, Italy). Chemoinvasion was measured in triplicate by
counting the number of cells which moved across the ﬁlter in 4 h for
CVEC, and in 18 h for HT1080. Data indicate number of cells
counted/well at 400· magniﬁcation in 10 random ﬁelds.
2.7. TIMP-4 immunoprecipitation
1 · 106 cells were treated with ONOO or DCP (100 lM, 500 lM
and 1 mM in 100 mM NaOH). Cells were lysed and 300 ng of proteins
were incubated with anti-TIMP-4 (Santa Cruz) 1 lg/ml overnight at
4 C. The antibody-protein complex was incubated with protein G
(2 h, 4 C). The pellets were then resuspended in loading buﬀer for wes-
tern blot analysis.
2.8. Zymography and reverse zymography
Gelatinolytic activity in medium conditioned for 24 h by contact
with cells (CM) was assayed by gelatin zymography as described
[14]. Brieﬂy, 50 ll of CM were mixed with loading buﬀer. Zymography
was carried out in SDS/9% PAGE containing 0.1% gelatin. To measure
changes in hTIMP-4 activity, reverse zymograms were prepared as de-
scribed [15]. Gelatin (1 mg/ml) and MMP-2 (2 mg/ml) (Calbiochem)
were co-polymerized into a 1 mm thick 15% polyacrylamide gel.
hTIMP-4 (100 ng and 1 lg), pretreated with 500 lM ONOO, was
electrophoresed for reverse zymography [14,15].
2.9. TIMP-4 activity
TIMP-4 activity was determined by measuring residual MMP-2
activity after incubating MMP-2 with hTIMP-4 (30 min, 23 C).
MMP-2 activity was assayed using the synthetic peptide DNP(2,4-dini-
trophenyl)-Pro-Leu-Gly-Leu-Trp-Ala-D-Arg-NH2 as described [16].
Brieﬂy, the ﬂuorogenic peptide (25 lM) was cleaved by MMP-2
(25 nM) in 50 mM Tris/100 mM NaCl2/10 mM CaCl2/0.05% Brij35
(pH 7.4). The compound contains a ﬂuorescent Trp residue and the
DNP quenching group at the N-terminus. The quenching of the Trp
ﬂuorescence in the intact substrate is relieved upon hydrolysis by
MMP-2, giving rise to a continuously recording ﬂuorescence assay.
The rate of change in ﬂuorescence of tryptophan (excitation 280 nm,
emission 346 nm) was monitored for 5 min at 37 C.
2.10. HPLC/ESI-MS/MS analysis
To identify the residues that could undergo post-translational mod-
iﬁcations we submitted TIMP-4 (1 lM), after ONOO or DCP reac-
tion (500 lM), to tryptic digestion and HPLC/ESI-MS/MS analysis.
For fragment analysis a LCQ DECA ion trap mass spectrometer
equipped with the ESI ion source was set such that one full MS scanwas followed by a zoom scan and a MS/MS scan on the most intense
ion from the MS spectrum. The identiﬁcation of the modiﬁed residues
was performed comparing the experimental MS/MS sequence data
with the sequence of TIMP-4, as present in the protein database for
human proteins (human.fasta), using Bioworks software 3.0 and
including, in the analysis, the possibility of a modiﬁcation correspond-
ing to 45 Da at the expense of Tyr residues and a modiﬁcation of 32 Da
at the expense of Cys residues.
2.11. Statistical analysis
Results are expressed as means ± S.E.M. Statistical analysis was per-
formed using Students t-test. P < 0.05 value was considered signiﬁ-
cant.3. Results
3.1. Expression and puriﬁcation of hTIMP-4
To evaluate the eﬀect of ONOO on hTIMP-4 activity, we
generated an active protein (human TIMP-4) using a His-
Tag containing vector in Escherichia coli. When analysed by
SDS/15% PAGE, consistent with the predicted molecular mass
based on the protein sequence, this preparation showed a sin-
gle band with molecular mass of 22 kDa (Fig. 1S), identiﬁed as
puriﬁed hTIMP-4 by mass spectrometry (data not shown) and
western blot using a speciﬁc anti-TIMP-4 antibody (Fig. 1B).
3.2. Eﬀect of ONOO on hTIMP-4 structure
To establish whether nitrative stress could alter the TIMP-4
structure, 1 lM hTIMP-4 was treated with ONOO (1 lM–
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23 C followed by SDS–PAGE under reducing conditions.
ONOO increased, concentration-dependently, the formation
of nitrotyrosine residues (Fig. 1A). Nitrated protein bands
were visible starting from 100 lM ONOO (Fig. 1A and B).
DCP failed to nitrate hTIMP-4 (Fig. 1A and B). In addition
to the nitration of the 22 kDa hTIMP-4 monomer, bands of
higher molecular mass were observed (Fig. 1), probably asso-
ciated with tyrosine-nitrated hTIMP-4 dimers (about
44 kDa) and trimers (about 66 kDa).
3.3. Identiﬁcation of hTIMP-4 nitrated residues
The TIMP-4 residues which underwent alteration by reac-
tion with ONOO where characterized by HPLC/ESI-MS/
MS analysis of the peptide fragments resulting from tryptic
digestion of the protein. The protein coverage ensured by this
analysis is around 60%. Of the eleven tyrosine residues of
hTIMP-4, three (Y133, Y152, Y164) could not be recognized
in the fragments obtained after trypsin digestion, because they
should be included in parts of the sequence not accessible to
the proteolytic enzyme. As shown by SDS–PAGE and western
blotting analysis (Fig. 1), TIMP-4 oligomers were also formed
upon peroxynitrite treatment. Therefore, the latter tyrosine
residues could also be involved in the formation of dityrosine
linkages through radical coupling of the phenol nuclei. It is
important to point out that modiﬁed TIMP-4 consists of aFig. 2. MS/MS spectrum of the m/z 1735.6 peak assigned to the hTIMP
ONOO-induced-nitration at Y195 and the sulﬁnic acid derivative at C197. T
from b9 of 163 amu, corresponding to a tyrosine residue, plus 45 amu, corresp
group bound to Y195; the loss of 32 amu, corresponding to two oxygen atoms
generated on C197.family of proteins containing single and multiple modiﬁcations
in the sequence, so that after tryptic treatment a complex mix-
ture of peptides is obtained. Comparison of the data showed
that four peptide fragments containing ONOO-derived mod-
iﬁcations were present, two as divalent ions, with m/z 733.8
(mass of 1465.6 amu) and m/z 868.8 (mass of 1735.6 amu),
and two as trivalent ions, both with m/z 611.9 (mass of
1832.8 amu). They corresponded to modiﬁed fragments 113–
125 (containing Y114), 187–199 (containing Y195 and C197),
and 186–199 (containing Y188 and Y190). The peptides with
masses of 1465.6 and 1832.8 amu contained a chemical species
with a mass increment of 45 amu with respect to the parent
peptides, which is compatible with the addition of a nitro
group to the phenol nucleus of tyrosine. In the ﬁrst case (mass
of 1465.6 amu), the fragment 113–125 contains Y114 modiﬁed.
The other fragment 186–199 (mass of 1832.8 amu) contains
three tyrosines in its sequence so that diﬀerent ion series can
be obtained, highlighting diﬀerent types of modiﬁcations;
therefore, one of the fragment shows nitration of Y188 and
the second nitration of Y190. The 186–199 fragment contains
also one cysteine (C197) that if not involved in a disulﬁde bond
could undergo modiﬁcation by peroxynitrite. This modiﬁca-
tion is identiﬁed in the ion with 1735.6 amu corresponding to
fragment 187–199, which showed a mass increment of
77 amu relative to the parent peptide. This corresponds to
the addition of a nitro group to a tyrosine residue and two oxy--4 187–199 peptide following its treatment with ONOO, revealing
he assignment of the y and b ion series is shown. In the ﬁgure the loss
onding to a NO2 group, is shown that allows the assignment of a nitro
from y3 supports the presence of a sulﬁnic acid derivative (R–S(O)OH)
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acid derivative (R–S(O)OH). The MS/MS spectrum of frag-
ment 187–199 is shown in Fig. 2, where the y and b ion series
are reported. A mass diﬀerence of 45 amu was detected be-
tween b8 and b9, that allows the unequivocal assignment of
a NO2 group bound to Y195, and a loss of 32 amu was de-
tected from y3, allowing the unambiguous determination of
the sulﬁnic acid derivative on C197.Fig. 3. ONOO inactivates TIMP-4 activity. ONOO-treated or
untreated hTIMP-4 was allowed to react with 2.5 lM MMP-2 for
30 min at 37 C. The inhibitory activity of hTIMP-4 samples incubated
in the absence of ONOO was taken as 100%. *P < 0.05, **P < 0.01,
***P < 0.001 versus untreated hTIMP-4. (n = 3).
Table 1





C FGF-2 C FGF-2
0.1% serum 16 ± 2 41 ± 2*** 20 ± 4 48 ± 2***
ONOO 15 ± 3 ND 19 ± 1 ND
TIMP-4 0.1 lg/ml 18 ± 1 26 ± 3## 18 ± 2 24 ± 4###
TIMP-4 1 lg/ml 10 ± 1* 15 ± 5### 19 ± 3* 18 ± 1###
TIMP-4 0.1 lg/ml
+ ONOO
18 ± 2 47 ± 2 22 ± 2 47 ± 4
TIMP-4 1 lg/ml
+ ONOO
17 ± 1 40 ± 4 21 ± 1 45 ± 3
hTIMP-4 was incubated with ONOO (500 lM) and then applied to
CVEC and HT1080 in the upper wells. 0.1% serum or FGF-2 (20 ng/
ml) in the bottom wells were used as chemoattractant molecules. Data
are results from three experiments run in triplicate and are reported as
cells counted/well. *P < 0.05, ***P < 0.001 versus basal (0.1% BCS for
CVEC and 0.1% FCS for HT1080). ##P < 0.01, ###P < 0.001 versus
growth factor-induced-invasion. ND = not done.
Fig. 4. Reverse zymogram for hTIMP-4 activity (dark band3.4. Inactivation of hTIMP-4 activity by ONOO
The eﬀects of ONOO on TIMP-4 activity towards MMP-2
were investigated by a ﬂuorimetric assay. When TIMP-4
(1 lM) was treated with ONOO (1 lM–1 mM), its inhibitory
activity was signiﬁcantly decreased in a concentration depen-
dent manner (Fig. 3). DCP had no eﬀect on hTIMP-4 activity
(data not shown). hTIMP-4 biological activity was also char-
acterized on endothelial (CVEC) and tumor cell (HT1080)
invasiveness (Figs. 2S and 3S). As revealed by gelatin zymog-
raphy, CVEC or HT1080 released MMPs which are instru-
mental for their invasiveness (Figs. 2SA and 3SA). FGF-2
stimulation of either CVEC or HT1080 promoted cell invasive-
ness. hTIMP-4 pretreatment reduced, concentration-depen-
dently, either baseline or stimulated invasiveness in both cell
lines (Figs. 2SB and 3SB). The decreased invasiveness pro-
duced by hTIMP-4 was unrelated to its eﬀect on cell viability,
since hTIMP-4 (2–200 nM) failed to inﬂuence either CVEC or
HT1080 growth (Table 1S). To study the eﬀect of ONOO on
hTIMP-4 activity, hTIMP-4 was pretreated with ONOO
(500 lM) before its addition to cell suspensions to be assayed
for invasiveness. ONOO-treated hTIMP-4 lost its inhibitory
properties on FGF-2-induced cell invasion (Table 1).
Reverse zymography conﬁrmed the ability of ONOO to in-
hibit hTIMP-4 activity. hTIMP-4 displayed a band at 22 kDa,
observed at the loading ﬁnal concentration of 1 lg but not at
100 ng (Fig. 4), denoting its ability to inhibit MMP-2 gelatin-
olytic activity when co-polymerized in the gel. ONOO
(500 lM) abolished hTIMP-4 inhibitory properties (Fig. 4).
3.5. Nitration of endogenous TIMP-4
In order to assess the biological relevance of TIMP-4 nitra-
tion, we directly exposed endothelial and tumor cells to
ONOO. As measured by TIMP-4 immunoprecipitation and
western blot analysis, ONOO treatment caused a concentra-
tion dependent nitration of TIMP-4 endogenously produced
by both CVEC and HT1080 cells (Fig. 5).4. Discussion
This study describes the role of ONOO on the biological
activity of TIMP-4. The synthesized hTIMP-4, inhibiting
MMP-2 activity, signiﬁcantly reduces basal or growth factor-
induced invasiveness of both endothelial and ﬁbrosarcoma tu-
mor cells. hTIMP-4 treatment with ONOO promotes its
nitration on tyrosine residues and oligomerization. ONOO-
treated hTIMP-4 loses its inhibitory eﬀect toward MMP-2
activity, consequently increasing endothelial and tumor cellon a light background). Representative gel of three.
Fig. 5. (A) Endothelial or (B) HT1080 tumor cells were treated with
ONOO. TIMP-4 was immunoprecipitated from the cell lysates and
western blot for nitrated-TIMP-4 was performed. A representative gel
out of three showing similar results is reported.
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gesting that TIMP-4 may be nitrated in pathophysiological
conditions contributing to cardiovascular diseases or tumor
progression.
Enhanced levels of oxidizing species, such as ONOO, are
produced by a variety of cell sources and are involved in many
pathophysiological processes [9,10,17]. Evidence for the gener-
ation of ONOO in vivo has been documented by the detec-
tion of nitrotyrosine in tumor and inﬂammatory sites
[9,10,18]. It has been estimated that the rate of ONOO forma-
tion may reach 1 mM/min in inﬂamed organ [11,18]. In the
present study we demonstrate that the production of patho-
physiological levels of ONOO aﬀect TIMP-4 activity. Since
ONOO has been also reported to activate pro-MMP-2 [1],
this may represent one key event in interpreting the MMP-2/
TIMP-4 imbalance aﬀecting many pathological processes.
In addition to the observed ONOO-induced hTIMP-4
nitration, we found oxidation of a cysteinyl thiol group to sul-
ﬁnic acid derivative. The most plausible explanation of this
ﬁnding may be related to a tiny fraction of protein containing
reduced disulﬁde bridge which escapes quantitative analysis.
Nevertheless, the analysis to identify the sites of protein mod-
iﬁcation clearly pinpoints TIMP-4 as a target of ONOO as it
triggers the nitration of four tyrosine residues. It is worth
emphasizing that inhibition of hTIMP-4 activity occurs with-
out pronounced degradation of the protein. Moreover, we
have noted the presence of nitrotyrosine positive bands at
molecular weights higher than that of monomeric hTIMP-4.
Since ONOO-treated hTIMP-4 was incubated with SDS/b-
mercaptoethanol sample buﬀer, it is conceivable that oligo-
mers had formed by dityrosine cross-linking.
In this study we have shown parallel inhibition of MMP-2
activity and consequently basal or growth factor-induced cell
invasiveness exerted by hTIMP-4. ONOO promotes
hTIMP-4 nitration and oligomerization, abolishing its inhibi-
tory actions toward both MMP-2 activity and cell invasive-
ness. ONOO, at approximately concentration 200 lM,
inactivates by 50% TIMP-4 in Tris buﬀer as detected by
MMP-2 assay (Fig. 3). Since Tris buﬀer aﬀects the reactivity
of peroxynitrite [13], we investigated the peroxynitrite-induced
TIMP-4 inactivation in phosphate buﬀer. In this condition,
accordingly with the literature, the ONOO IC50 was lower
(100 lM), although the buﬀer failed to change the pattern ofONOO-induced post-translation modiﬁcations of TIMP-4
(data not shown).
In addition, ONOO signiﬁcantly promoted the nitration at
tyrosine residues of TIMP-4 in cultured cells. In fact, treatment
of cell cultures with ONOO caused a concentration depen-
dent endogenous TIMP-4 nitration, reinforcing the pathophys-
iological relevance of this process. The low levels of cell-
produced-TIMP-4 did not allow us to evaluate whether
ONOO would promote TIMP-4 oligomerization. Although,
the demonstration of ONOO eﬃcacy in restraining TIMP-4
through nitration has been obtained on isolated enzyme or
cells, the results of the study illustrate a mechanism which
may be operant in vivo in diverse pathologies (e.g. in inﬂamed
tissues, in the ischemic heart).
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